Zobrazeno 1 - 10
of 178
pro vyhledávání: '"John S. Meyer"'
Autor:
Christopher Malon, Elena Brachtel, Eric Cosatto, Hans Peter Graf, Atsushi Kurata, Masahiko Kuroda, John S. Meyer, Akira Saito, Shulin Wu, Yukako Yagi
Publikováno v:
Analytical Cellular Pathology, Vol 35, Iss 2, Pp 97-100 (2012)
Despite the prognostic importance of mitotic count as one of the components of the Bloom – Richardson grade [3], several studies ([2, 9, 10]) have found that pathologists’ agreement on the mitotic grade is fairly modest. Collecting a set of more
Externí odkaz:
https://doaj.org/article/a779ca306ffb4affb30d9a1834e11fa9
Publikováno v:
Current Problems in Cancer. 37:181-191
Radiology has an integral part in the diagnosis and follow-up of patients with malignant bone tumors. These tumors must be treated in a multidisciplinary approach. Uniquely, the diagnosis of malignant bone tumors by pathologists relies on the radiolo
Publikováno v:
Archives of Pathology & Laboratory Medicine. 133:1826-1833
Context.—Mitotic figure counts are related to breast cancer behavior but have not been sufficiently reproducible to be accepted for clinical decision-making. Objective.—To improve reproducibility and accuracy of the mitotic count. Design.—Mitot
Autor:
Irma H. Russo, Neal Olson, Barbara A. Zehnbauer, Clara Milikowski, John S. Meyer, Andrew G. Glass, Consuelo Alvarez, Karen Lister, Jose Russo, Reza Parwaresch
Publikováno v:
Modern Pathology. 18:1067-1078
Questions of reproducibility and efficacy of histologic malignancy grading relative to alternative proliferation index measurements for outcome prediction remain unanswered. Microsections of specimens from the Cooperative Breast Cancer Tissue Resourc
Publikováno v:
International Journal of Gynecological Cancer. 10:372-381
Tecimer C, Doering DL, Goldsmith LJ, Meyer JS, Abdulhay G, Wittliff JL. Clinical relevance of urokinase-type plasminogen activator, its receptor and inhibitor type 1 in ovarian cancer. Urokinase-type plasminogen activator (uPA), its receptor (uPAR) a
Autor:
John S. Meyer, John S. Spratt
Publikováno v:
Journal of Surgical Oncology. 71:198-205
The strategy of therapy for any neoplasm is determined to a significant degree by the biological characteristics of the neoplasm. The ones benefited most by surgical ablation are the cancers that grow locally but never metastasize. The second group i
Autor:
John S. Meyer
Publikováno v:
Journal of Surgical Oncology. 69:212-218
Background and Objectives Sentinel lymph node biopsy is a practical surgical procedure with high sensitivity for detection of metastases from breast carcinoma in the axilla. It offers economy by avoidance of axillary dissection in the majority of bre
Publikováno v:
Cancer. 77:1459-1464
summary of follow-up data on all the studied patients is shown in Table 1. Parametric survival analysis pro- duced inconsistent estimates for three histologic sub- types (mucinous, lobular, and ducto lobular). Given such inconsistency, we cannot draw
Publikováno v:
Cancer. 76:1009-1018
Background. Standard, nonparametric statistical methods measure the interaction of covariates with survival rate or relative risk. Conversely, parametric methods measure the interaction of covariates with the two cardinal features of malignant potent
Autor:
Michael A. Province, John S. Meyer
Publikováno v:
Cancer. 74:2287-2299
Background. S-phase fraction (SPF) predicts the prognosis of patients with breast cancer independently of tumor size, axillary metastasis, estrogen receptor (ER) and progesterone receptor (PgR), and patient age. Whether SPF is best measured by DNA la